Abstract
Background: We present a 20-year surgical experience with spermatic cord sarcoma, describe prognostic features, and evaluate the results of surgical and adjunctive treatments.
Methods: Forty-seven patients were identified from an institutional database. Disease-free survival was calculated, and prognostic factors such as tumor grade, size, extent of operation, and adjuvant therapy were analyzed.
Results: The median patient age was 58 years (range, 16–83 years), and the median follow-up was 51 months (range, .5–226 months). The most common tumor types included liposarcoma (51%), leiomyosarcoma (19%), embryonal rhabdomyosarcoma (13%), and malignant fibrous histiocytoma (11%). Twenty-nine (62%) patients had high-grade tumors, 21 (45%) were treated with adjuvant radiation, and 9 (19%) received chemotherapy. The overall 5- and 10-year disease-specific survival was 75% and 55%, respectively. No specific prognostic factors were identified for recurrence or disease-free survival. In 21 patients who underwent reoperative wide resection after a prior incomplete resection, a trend toward improved disease-free survival was noted (P < .059). Of these, six (29%) had residual viable sarcoma. We could not demonstrate a therapeutic effect of adjuvant radiation or chemotherapy.
Conclusions: We demonstrated that aggressive surgical strategies, including reoperative wide resection, significantly decrease local recurrence and may improve disease free-survival in select patients with spermatic cord sarcoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Russo P, Brady MS, Conlon K, et al. Adult urological sarcoma. J Urol 1992; 147:1032–7.
Frank I, Takahashi S, Tsukamoto T, Lieber MM. Genitourinary sarcomas and carcinosarcomas in adults. In: Vogelzang NJ, Shipley WU, Scardino PT, Coffey DS, eds. Comprehensive Textbook of Genitourinary Oncology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2000:1110–3.
Lewis JJ, Leung D, Woodruff J, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 1998; 228:355–65.
Lewis JJ, Leung D, Espat J, Woodruff J, Brennan MF. Effect of reresection in extremity soft tissue sarcoma. Ann Surg 1999; 231:655–63.
Sogani PC, Grabstald H, Whitmore WF. Spermatic cord sarcoma in adults. J Urol 1978; 120:301–5.
Blitzer PH, Dosoretz DE, Proppe KH, Shipley WU. Treatment of malignant tumors of the spermatic cord: a study of 10 cases and a review of the literature. J Urol 1981; 126:611–4.
Merimsky O, Terrier P, Bonvalot S, Le Pechoux C, Delord J, Le Cesne A. Spermatic cord sarcoma in adults. Acta Oncol 1999; 38:635–8.
Konety BK, Singh J, Lyne JC, Salup RR. Leiomyosarcoma with osteoclast-like giant cells of the spermatic cord: a case report and review of the literature. Urol Int 1996; 56:259–62.
Ballo MT, Zagars GK, Pisters PWT, Feig BW, Patel SR, Von Eschenbach AC. Spermatic cord sarcoma: outcome, patterns of failure and management. J Urol 2001; 166:1306–10.
Beech DJ, Pollack RE. Surgical management of soft tissue sarcoma. Hematol Oncol Clin North Am 1995; 9:707–18.
Pisters PWT, Harrison LB, Leung DH, Woodruff JM, Casper ES, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996; 14:859–68.
Sadoski C, Suit HD, Rosenberg A, Mankin H, Efird J. Preoperative radiation, surgical margins and local control of extremity sarcomas in soft tissues. J Surg Oncol 1993; 53:223–30.
Alektiar KM, Velasco J, Zelefsky MJ, et al. Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity. Int J Radiat Oncol Biol Phys 2000; 48:1051–8.
Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefits of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998; 16:197–203.
Heslin MJ, Woodruff J, Brennan MF. Prognostic significance of a positive microscopic margin in high-risk extremity soft tissue sarcoma: implications for management. J Clin Oncol 1996; 14:473–8.
Collin CF, Friedrich C, Godbold J, Hajdu S, Brennan MF. Prognostic factors for local recurrence and survival in patients with localized extremity soft-tissue sarcoma. Semin Surg Oncol 1988; 4:30–7.
Lewis JJ, Leung D, Casper ES, Woodruff J, Hajdu SI, Brennan MF. Multifactorial analysis of long-term follow-up (more than 5 years) of primary extremity sarcoma. Arch Surg 1999; 134:190–4.
Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996; 14:1679–89.
Rabbani F, Wright J, McLoughlin M. Sarcomas of the spermatic cord: significance of wide local excision. Can J Urol 1997; 4:366–76.
Brooks AD, Bowne WB, Delgado R, et al. Soft tissue sarcomas of the groin: diagnosis, management, and prognosis. J Am Coll Surg 2001; 193:130–6.
Srigley JR. The paratesticular region: histoanatomic and general considerations. Semin Diagn Pathol 2000; 17:258–69.
Grey LF, Sorial RF, Shaw WH. Spermatic cord sarcoma: leiomyosarcoma and retroperitoneal lymph node dissection. Urology 1986; 27:28–31.
Cardenosa G, Papanicolau N, Fung CY, et al. Spermatic cord sarcomas: sonographic and CT features. Urol Radiol 1990; 163–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Coleman, J., Brennan, M.F., Alektiar, K. et al. Adult Spermatic Cord Sarcomas: Management and Results. Ann Surg Oncol 10, 669–675 (2003). https://doi.org/10.1245/ASO.2003.11.014
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1245/ASO.2003.11.014